Iqvia Holdings (IQV) EBT Growth (1y) (2013 - 2026)
Iqvia Holdings (IQV) EBT Growth (1y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.91 Bn | 209.85 Bn | 8.34 Bn | 12.58% |
| 2 | Danaher | 141.30 Bn | 136.96 Bn | 3.61 Bn | 64.58% |
| 3 | Idexx Laboratories | 46.31 Bn | 46.12 Bn | 779.09 Mn | 15.14% |
| 4 | Agilent Technologies | 39.79 Bn | 37.98 Bn | 990.00 Mn | 56.92% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | -6.81% |
| 6 | Natera | 39.08 Bn | 37.98 Bn | 696.04 Mn | -27.03% |
| 7 | Illumina | 30.17 Bn | 29.00 Bn | 770.00 Mn | -15.03% |
| 8 | Mettler Toledo International | 28.68 Bn | 28.63 Bn | 650.22 Mn | 16.39% |
| 9 | Quest Diagnostics | 26.21 Bn | 25.59 Bn | 1.03 Bn | 7.29% |
| 10 | Labcorp Holdings | 25.83 Bn | 24.85 Bn | 1.01 Bn | 16.17% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -6.81% |
| Mar 31, 2026 | 1.55% |
| Dec 31, 2025 | -1.29% |
| Sep 30, 2025 | 16.91% |
| Jun 30, 2025 | -25.92% |
| Mar 31, 2025 | -5.00% |
| Dec 31, 2024 | 45.84% |
| Sep 30, 2024 | 0.00% |
| Jun 30, 2024 | 16.27% |
| Mar 31, 2024 | -6.08% |
| Dec 31, 2023 | 35.64% |
| Sep 30, 2023 | -3.06% |
| Jun 30, 2023 | 14.33% |
| Mar 31, 2023 | -9.50% |
| Dec 31, 2022 | -26.86% |
| Sep 30, 2022 | 31.87% |
| Jun 30, 2022 | 47.75% |
| Mar 31, 2022 | 55.64% |
| Dec 31, 2021 | 93.81% |
| Sep 30, 2021 | 167.65% |